Mezzasalma Advisors LLC grew its holdings in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 21.9% in the second quarter, Holdings Channel.com reports. The firm owned 13,546 shares of the insurance provider’s stock after buying an additional 2,437 shares during the period. Mezzasalma Advisors LLC’s holdings in Allstate were worth $2,727,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently modified their holdings of the company. Chicago Partners Investment Group LLC raised its position in shares of Allstate by 3.4% in the second quarter. Chicago Partners Investment Group LLC now owns 5,565 shares of the insurance provider’s stock valued at $1,100,000 after purchasing an additional 183 shares during the period. International Assets Investment Management LLC purchased a new position in Allstate in the 2nd quarter valued at approximately $141,000. Gladwyn Financial Advisors Inc. purchased a new position in Allstate in the 2nd quarter valued at approximately $146,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Allstate during the 2nd quarter valued at $13,951,000. Finally, Quotient Wealth Partners LLC lifted its position in shares of Allstate by 7.3% during the second quarter. Quotient Wealth Partners LLC now owns 1,264 shares of the insurance provider’s stock worth $255,000 after acquiring an additional 86 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Allstate Price Performance
Shares of NYSE ALL opened at $195.96 on Friday. The stock’s 50-day simple moving average is $205.61 and its two-hundred day simple moving average is $200.87. The Allstate Corporation has a twelve month low of $176.00 and a twelve month high of $215.70. The firm has a market capitalization of $51.64 billion, a P/E ratio of 9.21, a P/E/G ratio of 0.72 and a beta of 0.38. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.37.
Analyst Upgrades and Downgrades
ALL has been the subject of several recent research reports. Cantor Fitzgerald upgraded Allstate to a “hold” rating in a research report on Wednesday, August 13th. Roth Capital set a $230.00 target price on Allstate and gave the stock a “buy” rating in a research note on Friday, September 26th. UBS Group lifted their target price on Allstate from $235.00 to $250.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. BMO Capital Markets increased their price target on shares of Allstate from $230.00 to $235.00 and gave the stock an “outperform” rating in a report on Wednesday, August 20th. Finally, Evercore ISI set a $233.00 price objective on shares of Allstate and gave the company an “in-line” rating in a research report on Wednesday, October 1st. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Allstate presently has a consensus rating of “Moderate Buy” and a consensus price target of $234.60.
Check Out Our Latest Stock Report on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- Retail Stocks Investing, Explained
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.